Update on CAR-NK cell therapy work at MD Anderson
William Wierda, MD, PhD, of The University of Texas MD Anderson Cancer Center, Houston, TX, gives us the latest news on the CAR-NK cell therapy work that is ongoing at MD Anderson. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
Suggested videos

Kenneth Anderson: What are the next steps to a myeloma cure?
VJHemOnc – Video Journal of Hematology & HemOnc · 4:01

MD Anderson and Takeda announce collaboration to develop off-the-shelf CAR NK-cell therapies
UT MD Anderson Cancer Center · 1:33

Future perspectives in frontline MCL treatment and management: a European and US view
VJHemOnc – Video Journal of Hematology & HemOnc · 17:17

CAR NK therapy: An experimental immunotherapy treatment for blood cancers
UT MD Anderson Cancer Center · 2:03

Welcome to the Video Journal of Hematology & Hematological Oncology 🎥🩸
VJHemOnc – Video Journal of Hematology & HemOnc · 3:08

B-cell lymphoma survivor helped with CAR NK therapy clinical trial
UT MD Anderson Cancer Center · 1:06

IGHV4-34 and IGHV1-69: precision CAR T-cell targeting in CLL
VJHemOnc – Video Journal of Hematology & HemOnc · 2:41

CAR NK-Cell Therapy, the future of cancer treatment?
Alcimed · 1:31

Beyond BTK inhibition: overcoming resistance and exploring new treatment strategies in CLL
VJHemOnc – Video Journal of Hematology & HemOnc · 18:48

How does cell therapy work?
UT MD Anderson Cancer Center · 27:02

Current role of AI in hematology/oncology: separating the hype from reality
VJHemOnc – Video Journal of Hematology & HemOnc · 2:54

How MD Anderson’s ORBIT Platform drives new biologics therapies
UT MD Anderson Cancer Center · 2:46